Katarzyna Śladowska

3PUBLICATIONS

10CO-AUTHORS

Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 23, 2026

Association Between Dinutuximab Beta Exposure and Post-End-of-Treatment Survival in Neuroblastoma: A Weighted Patient-Level Analysis of Three Clinical Studies.

|Jun 03, 2025

Efficacy and Safety of Anti-GD2 Immunotherapy with Dinutuximab Beta in the Treatment of Relapsed/Refractory High-Risk Neuroblastoma.

Aleksandra Wieczorek, Katarzyna Śladowska, Holger N Lode

|Sep 25, 2024

Efficacy and safety of mirikizumab compared with currently approved biologic drugs for the treatment of ulcerative colitis: A systematic review and network meta-analysis.

Paweł Moćko, Magdalena Koperny, Katarzyna Śladowska

Pageof 1

Frequent Collaborators

2 joint publications

Przemysław Holko

2 joint publications

Paweł Kawalec

1 joint publications

Paweł Moćko

1 joint publications

Magdalena Koperny

1 joint publications

Iwona Kowalska-Bobko

1 joint publications

Aleksandra Wieczorek

1 joint publications

Holger N Lode

1 joint publications

Roberto Luksch

1 joint publications

Lucas Moreno

1 joint publications

Shifra Ash

Frequent Collaborators

2 joint publications

Przemysław Holko

2 joint publications

Paweł Kawalec

1 joint publications

Paweł Moćko

1 joint publications

Magdalena Koperny